• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

联合 CDAI 和血液指标评估回肠结肠克罗恩病的内镜活动。

Combined use of CDAI and blood indices for assessing endoscopic activity in ileocolic Crohn's disease.

机构信息

Department of Gastroenterology, Affiliated Hospital of Yangzhou University, Yangzhou, 225009, Jiangsu, China.

Medical College of Yangzhou University, Jiangsu, China.

出版信息

BMC Gastroenterol. 2023 Sep 28;23(1):337. doi: 10.1186/s12876-023-02968-0.

DOI:10.1186/s12876-023-02968-0
PMID:37770845
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10540500/
Abstract

BACKGROUND

Mucosal healing has become the primary treatment target for patients with Crohn's disease (CD). We aimed to develop a noninvasive and convenient tool to evaluate the endoscopic activity in patients with ileocolic CD.

METHODS

A retrospective multicenter study including 300 CD patients (training, 210 patients; test, 90 patients) was conducted at two tertiary referral centers. Independent risk factors associated with endoscopic activity were explored, which were then combined into a comprehensive index. The predictive performance was evaluated with the area under receiver operating characteristic curve (ROC). Cohen's Kappa was adopted to examine the consistency between each indicator and endoscopic activity.

RESULTS

A total of 210 CD patients were recruited in the training cohort. We found that Crohn's Disease Activity Index (CDAI), C-reactive protein (CRP) and platelet-to-lymphocyte percentage ratio (PLpR) were independently associated with endoscopic activity. Additionally, the comprehensive index generated from the above three indices achieved good discrimination and performed better than CDAI in AUC (0.849 vs. 0.769, P < 0.05). This was further well demonstrated by the external test cohort, which showed good discrimination (AUC: 0.84, 95% CI: 0.744-0.936). Intra-individual comparison revealed the comprehensive index to be superior in the prediction of endoscopic activity. In the subgroup analysis, the AUC of comprehensive index was significantly higher than CDAI especially in inflammatory phenotype (0.824 vs. 0.751, P < 0.05).

CONCLUSION

Combining CDAI, CRP and PLpR significantly improved the accuracy for predicting endoscopic activity in ileocolic CD, which can help better monitor an endoscopic flare.

摘要

背景

黏膜愈合已成为克罗恩病(CD)患者的主要治疗目标。我们旨在开发一种非侵入性且方便的工具来评估回肠结肠 CD 患者的内镜活动。

方法

在两个三级转诊中心进行了一项回顾性多中心研究,共纳入 300 例 CD 患者(训练队列 210 例,测试队列 90 例)。探讨与内镜活动相关的独立危险因素,并将其组合成综合指数。采用接受者操作特征曲线(ROC)下面积评估预测性能。采用 Cohen's Kappa 检验评估各指标与内镜活动的一致性。

结果

共纳入 210 例 CD 患者进入训练队列。我们发现克罗恩病活动指数(CDAI)、C 反应蛋白(CRP)和血小板与淋巴细胞比值(PLpR)与内镜活动独立相关。此外,由上述三个指标生成的综合指数具有良好的区分度,在 AUC 方面优于 CDAI(0.849 比 0.769,P<0.05)。这在外测队列中得到了进一步证实,其 AUC 为 0.84(95%CI:0.744-0.936),具有良好的区分度。个体内比较显示综合指数在预测内镜活动方面具有优势。亚组分析显示,综合指数的 AUC 明显高于 CDAI,尤其是在炎症表型中(0.824 比 0.751,P<0.05)。

结论

联合 CDAI、CRP 和 PLpR 可显著提高对回肠结肠 CD 内镜活动的预测准确性,有助于更好地监测内镜下的炎症发作。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a770/10540500/f2c991c0f528/12876_2023_2968_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a770/10540500/5526e93ee6ed/12876_2023_2968_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a770/10540500/660ca500a087/12876_2023_2968_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a770/10540500/06f706e8c836/12876_2023_2968_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a770/10540500/c64f6eaae6d8/12876_2023_2968_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a770/10540500/f2c991c0f528/12876_2023_2968_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a770/10540500/5526e93ee6ed/12876_2023_2968_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a770/10540500/660ca500a087/12876_2023_2968_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a770/10540500/06f706e8c836/12876_2023_2968_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a770/10540500/c64f6eaae6d8/12876_2023_2968_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a770/10540500/f2c991c0f528/12876_2023_2968_Fig5_HTML.jpg

相似文献

1
Combined use of CDAI and blood indices for assessing endoscopic activity in ileocolic Crohn's disease.联合 CDAI 和血液指标评估回肠结肠克罗恩病的内镜活动。
BMC Gastroenterol. 2023 Sep 28;23(1):337. doi: 10.1186/s12876-023-02968-0.
2
Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC.基于 SONIC 数据的事后分析验证克罗恩病患者内镜活动评分的有效性。
Gastroenterology. 2013 Nov;145(5):978-986.e5. doi: 10.1053/j.gastro.2013.08.010. Epub 2013 Aug 14.
3
Visceral adiposity and inflammatory bowel disease.内脏肥胖与炎症性肠病。
Int J Colorectal Dis. 2021 Nov;36(11):2305-2319. doi: 10.1007/s00384-021-03968-w. Epub 2021 Jun 9.
4
[Value of different endoscopic scoring methods in assessing disease activity in pediatric Crohn's disease].[不同内镜评分方法在评估儿童克罗恩病疾病活动度中的价值]
Zhongguo Dang Dai Er Ke Za Zhi. 2024 Jun 15;26(6):584-591. doi: 10.7499/j.issn.1008-8830.2311103.
5
Biomarker-Based Models Outperform Patient-Reported Scores in Predicting Endoscopic Inflammatory Disease Activity.基于生物标志物的模型在预测内镜炎症性疾病活动方面优于患者报告评分。
Inflamm Bowel Dis. 2018 Jan 18;24(2):277-285. doi: 10.1093/ibd/izx018.
6
Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI.粪便钙卫蛋白与克罗恩病简单内镜评分(SES-CD)的相关性比 CRP、血白细胞和 CDAI 更密切。
Am J Gastroenterol. 2010 Jan;105(1):162-9. doi: 10.1038/ajg.2009.545. Epub 2009 Sep 15.
7
Platelet Activation Markers Are Associated with Crohn's Disease Activity in Patients with Low C-Reactive Protein.血小板活化标志物与低C反应蛋白患者的克罗恩病活动相关。
Dig Dis Sci. 2015 Nov;60(11):3418-23. doi: 10.1007/s10620-015-3745-2. Epub 2015 Jun 16.
8
Magnetic resonance enterography changes after antibody to tumor necrosis factor (anti-TNF) alpha therapy in Crohn's disease: correlation with SES-CD and clinical-biological markers.克罗恩病患者接受肿瘤坏死因子α抗体(抗TNF)治疗后磁共振小肠造影的变化:与SES-CD及临床生物学标志物的相关性
BMC Med Imaging. 2016 May 5;16(1):37. doi: 10.1186/s12880-016-0139-7.
9
Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial.SONIC 试验中克罗恩病的临床疾病活动、C 反应蛋白正常化和黏膜愈合。
Gut. 2014 Jan;63(1):88-95. doi: 10.1136/gutjnl-2013-304984. Epub 2013 Aug 23.
10
Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn's disease.替代标志物和临床指标单独或联合作为抗TNF治疗的腔内克罗恩病内镜缓解的指标。
Scand J Gastroenterol. 2012 May;47(5):528-37. doi: 10.3109/00365521.2012.660542. Epub 2012 Feb 23.

引用本文的文献

1
A nomogram for predicting small bowel mucosal healing in pediatric Crohn's disease.一种用于预测儿童克罗恩病小肠黏膜愈合情况的列线图。
Front Med (Lausanne). 2025 Jun 24;12:1582238. doi: 10.3389/fmed.2025.1582238. eCollection 2025.
2
Expression Profile of Serum CircFUNDC1 and CircUHRF1 Can Differentiate Between Colorectal Cancer and Inflammatory Bowel Diseases (Ulcerative Colitis and Crohn's Disease).血清CircFUNDC1和CircUHRF1的表达谱可区分结直肠癌与炎症性肠病(溃疡性结肠炎和克罗恩病)。
J Clin Lab Anal. 2025 Jun;39(11):e70039. doi: 10.1002/jcla.70039. Epub 2025 May 16.
3
Cancer Stem Cells and the Tumor Microenvironment in Tumor Drug Resistance.

本文引用的文献

1
Prealbumin and Retinol-Binding Protein 4: The Promising Inflammatory Biomarkers for Identifying Endoscopic Remission in Crohn's Disease.前白蛋白和视黄醇结合蛋白4:用于识别克罗恩病内镜缓解的有前景的炎症生物标志物。
J Inflamm Res. 2021 Dec 25;14:7371-7379. doi: 10.2147/JIR.S343125. eCollection 2021.
2
Long-term Disease Course of Crohn's Disease: Changes in Disease Location, Phenotype, Activities, and Predictive Factors.克罗恩病的长期病程:病变部位、表型、活动度的变化及预测因素。
Gut Liver. 2022 Mar 15;16(2):157-170. doi: 10.5009/gnl210118.
3
Blood-based prognostic biomarkers in Crohn's Disease patients on biologics: a promising tool to predict endoscopic outcomes.
肿瘤耐药中的癌症干细胞与肿瘤微环境
Stem Cell Rev Rep. 2023 Oct;19(7):2141-2154. doi: 10.1007/s12015-023-10593-3. Epub 2023 Jul 21.
生物制剂治疗的克罗恩病患者的基于血液的预后生物标志物:预测内镜结局的有前途的工具。
Expert Opin Biol Ther. 2021 Aug;21(8):1133-1141. doi: 10.1080/14712598.2021.1935857. Epub 2021 Jun 13.
4
C-reactive protein/abumin ratio is a useful biomarker for predicting the mucosal healing in the Crohn disease: A retrospective study.C 反应蛋白/白蛋白比值是预测克罗恩病黏膜愈合的有用生物标志物:一项回顾性研究。
Medicine (Baltimore). 2021 Mar 12;100(10):e24925. doi: 10.1097/MD.0000000000024925.
5
Metabolomics as a Promising Resource Identifying Potential Biomarkers for Inflammatory Bowel Disease.代谢组学作为一种有前景的资源,用于识别炎症性肠病的潜在生物标志物。
J Clin Med. 2021 Feb 6;10(4):622. doi: 10.3390/jcm10040622.
6
Platelet-to-lymphocyte percentage ratio index: a simple non-invasive index to monitor the endoscopic activity in Crohn's disease.血小板与淋巴细胞百分比比值指数:一种监测克罗恩病内镜活动的简单非侵入性指标。
Therap Adv Gastroenterol. 2020 Dec 21;13:1756284820979442. doi: 10.1177/1756284820979442. eCollection 2020.
7
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD.STRIDE-II:炎症性肠病(STRIDE)国际研究组织(IOIBD)治疗靶点选择更新:确定炎症性肠病靶向治疗策略的治疗目标。
Gastroenterology. 2021 Apr;160(5):1570-1583. doi: 10.1053/j.gastro.2020.12.031. Epub 2021 Feb 19.
8
A Pilot Study Evaluating Novel Urinary Biomarkers for Crohn's Disease.一项评估克罗恩病新型尿液生物标志物的初步研究。
Inflamm Intest Dis. 2020 Nov;5(4):212-220. doi: 10.1159/000510682. Epub 2020 Oct 14.
9
Clinical evaluation of vitamin D status and its relationship with disease activity and changes of intestinal immune function in patients with Crohn's disease in the Chinese population.中国人群克罗恩病患者的维生素 D 状态临床评估及其与疾病活动度和肠道免疫功能变化的关系。
Scand J Gastroenterol. 2021 Jan;56(1):20-29. doi: 10.1080/00365521.2020.1844793. Epub 2020 Nov 18.
10
Significance of endoscopic deep small bowel evaluation using balloon-assisted enteroscopy for Crohn's disease in clinical remission.采用气囊辅助式小肠镜对处于临床缓解期的克罗恩病行内镜下深度小肠评估的意义。
J Gastroenterol. 2021 Jan;56(1):25-33. doi: 10.1007/s00535-020-01737-0. Epub 2020 Oct 19.